Aggression is comorbid with numerous neuropsychiatric disorders across the lifespan. Understanding is limited as to how such conditions might increase predisposition to aggression. Furthermore, treatment for aggression, which includes both behavioral and pharmacological approaches, can be incompletely effective, and in the case of pharmacotherapy, places patients at high risk for serious side effects. The overall goal of my current research is to identify how the nicotinic acetylcholinergic receptor system governs aggressive behavior in preclinical models, with the ultimate goal of translating these findings into improved treatments for clinical populations.
- Van Schalkwyk GI, Lewis AS, Qayyum Z, Koslosky K, Picciotto MR, Volkmar FR (2015) Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder. J Autism Dev Disord. In press
- Picciotto MR, Lewis AS, van Schalkwyk GI, Mineur YS (2014) Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states. Neuropharmacology. In press.
- Lewis AS, Picciotto MR (2013) High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness. Psychopharmacology (Berl) 229:477-485.
- Lewis AS, Schwartz E, Chan CS, Noam Y, Shin M, Wadman WJ, Surmeier DJ, Baram TZ, Macdonald RL, Chetkovich DM (2009) Alternatively spliced isoforms of TRIP8b differentially control h channel trafficking and function. Journal of Neuroscience 29:6250-6265.
- Lewis AS, Vaidya SP, Blais CA, Liu Z, Stoub TR, Brager DH, Chen X, Bender RA, Estep CM, Popov AB, Kang CE, van Veldhoven PP, Bayliss DA, Nicholson DA, Powell CM, Johnston D, Chetkovich DM (2011) Deletion of the HCN channel auxiliary subunit TRIP8b impairs